Month: September 2021

AIM ImmunoTech Announces Clinical Trial Agreement for a Phase 2a Human Challenge Trial of Ampligen as a Potential Intranasal Prophylaxis Against Respiratory Viruses

Cybeats Addresses the Electric Vehicle Security and Charging Station Markets; Relay Comments on Mandated Software Requirements for EV Manufacturing and Infrastructure via SBOM

Toronto, Ontario--(Newsfile Corp. - September 29, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the...

error: Content is protected !!